|
Clinical trials Randomized controlled (CONSORT agreement)
Citations 111-120 of 248 total displayed.
|
Past content
(since Mar 2001):
|
- BRIEF COMMUNICATIONS
TENS for the treatment of writer’s cramp dystonia: A randomized, placebo-controlled study
- M. Tinazzi, S. Farina, K. Bhatia, A. Fiaschi, G. Moretto, L. Bertolasi, S. Zarattini, and N. Smania
Neurology 2005; 64: 1946-1948.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A sham stimulation-controlled trial of rTMS of the unaffected hemisphere in stroke patients
- C. G. Mansur, F. Fregni, P. S. Boggio, M. Riberto, J. Gallucci-Neto, C. M. Santos, T. Wagner, S. P. Rigonatti, M. A. Marcolin, and A. Pascual-Leone
Neurology 2005; 64: 1802-1804.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Who can say yes (or no) to a physician—and how does the physician know they can?
- Michael P. McQuillen and Pierre Tariot
Neurology 2005; 64: 1494-1495.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
High-dose creatine therapy for Huntington disease: A 2-year clinical and MRS study
- S. J. Tabrizi, A. M. Blamire, D. N. Manners, B. Rajagopalan, P. Styles, A.H.V. Schapira, and T. T. Warner
Neurology 2005; 64: 1655-1656.
[Full text]
[PDF]
- EDITORIALS
Treating fatigue in patients with MS: One step forward, one step back
- Steven R. Schwid and T. Jock Murray
Neurology 2005; 64: 1111-1112.
[Full text]
[PDF]
- ARTICLES
Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
- B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, L. Rumbach, T. Moreau, J. Pelletier, C. Lubetzki, M. Clanet, and French Modafinil Study Group
Neurology 2005; 64: 1139-1143.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
- D. M. Wingerchuk, E. E. Benarroch, P. C. O’Brien, B. M. Keegan, C. F. Lucchinetti, J. H. Noseworthy, B. G. Weinshenker, and M. Rodriguez
Neurology 2005; 64: 1267-1269.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS
- S. N. Scelsa, D. J.L. MacGowan, H. Mitsumoto, T. Imperato, A. J. LeValley, M. H. Liu, M. DelBene, and M. Y. Kim
Neurology 2005; 64: 1298-1300.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
- C. Polman, F. Barkhof, M. Sandberg-Wollheim, A. Linde, O. Nordle, T. Nederman for the Laquinimod in Relapsing MS Study Group
Neurology 2005; 64: 987-991.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
The effect of levetiracetam on essential tremor
- Khalafalla O. Bushara, Taimur Malik, and Rupert E. Exconde
Neurology 2005; 64: 1078-1080.
[Abstract]
[Full text]
[PDF]
|
|
